Review



dexamethasone disodium phosphate (ilsung co., seoul, republic of korea)  (Ilsung Pharmaceuticals Co Ltd)

 
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Ilsung Pharmaceuticals Co Ltd dexamethasone disodium phosphate (ilsung co., seoul, republic of korea)
    A, B Changes in body weight and food intake in hamsters. MT, mechanical trauma only; 5-FU + MT, mechanical trauma with 5-FU administration; TMSC, mechanical trauma with 5-FU administration, tonsil-derived MSC injection; <t>DEXA,</t> mechanical trauma with 5-FU administration, <t>dexamethasone</t> injection; saline, mechanical trauma with 5-FU administration, saline injection
    Dexamethasone Disodium Phosphate (Ilsung Co., Seoul, Republic Of Korea), supplied by Ilsung Pharmaceuticals Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexa/dexamethasone+dexa+s/pmc06992808-93-0-5
    Average 90 stars, based on 1 article reviews
    dexamethasone disodium phosphate (ilsung co., seoul, republic of korea) - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Wound Healing Promoting Activity of Tonsil-Derived Stem Cells on 5-Fluorouracil-Induced Oral Mucositis Model"

    Article Title: Wound Healing Promoting Activity of Tonsil-Derived Stem Cells on 5-Fluorouracil-Induced Oral Mucositis Model

    Journal: Tissue Engineering and Regenerative Medicine

    doi: 10.1007/s13770-019-00226-7

    A, B Changes in body weight and food intake in hamsters. MT, mechanical trauma only; 5-FU + MT, mechanical trauma with 5-FU administration; TMSC, mechanical trauma with 5-FU administration, tonsil-derived MSC injection; DEXA, mechanical trauma with 5-FU administration, dexamethasone injection; saline, mechanical trauma with 5-FU administration, saline injection
    Figure Legend Snippet: A, B Changes in body weight and food intake in hamsters. MT, mechanical trauma only; 5-FU + MT, mechanical trauma with 5-FU administration; TMSC, mechanical trauma with 5-FU administration, tonsil-derived MSC injection; DEXA, mechanical trauma with 5-FU administration, dexamethasone injection; saline, mechanical trauma with 5-FU administration, saline injection

    Techniques Used: Derivative Assay, Injection, Saline

    A, B Immunohistochemistry for CD31 on days 10 and 14. The TMSC group showed significantly higher CD31 expression compared with the 5-FU + MT and saline groups on day 10. The TMSC group showed significantly greater CD31 expression than the DEXA group on day 14. *p<0.05, ***p<0.005. × 200
    Figure Legend Snippet: A, B Immunohistochemistry for CD31 on days 10 and 14. The TMSC group showed significantly higher CD31 expression compared with the 5-FU + MT and saline groups on day 10. The TMSC group showed significantly greater CD31 expression than the DEXA group on day 14. *p<0.05, ***p<0.005. × 200

    Techniques Used: Immunohistochemistry, Expressing, Saline

    Related Articles

    other:

    Article Title: Chlorpheniramine-induced anaphylaxis
    Article Snippet: Previously, she had experienced an inject-site rash after administration of intramuscular chlorpheniramine and fully recovered after administration of intravenous dexamethasone (Dexa-S, Ilsung Pharma Co, Ltd), although she had no problems with the drug when administered orally.

    Article Title: Wound Healing Promoting Activity of Tonsil-Derived Stem Cells on 5-Fluorouracil-Induced Oral Mucositis Model
    Article Snippet: DEXA group Dexamethasone disodium phosphate (Ilsung Pharmaceuticals Co., Seoul, Republic of Korea, 5 mg/ml) was diluted to 1 mg/kg in a phosphate-buffered saline (PBS, pH 7.4) solution and injected into the submucosa around the mucosa defect site on day 7 using 26-gauge sterile needle syringe.

    Article Title: Chlorpheniramine-induced anaphylaxis
    Article Snippet: After receiving emergency care for anaphylaxis, including fluid resuscitation and intravenous steroids treatment with dexamethasone (Dexa-S, Ilsung Pharma Co, Ltd, Seoul, Korea), she was fully recovered.

    Article Title: Factors Associated With the Benefits of Concurrent Administration of Intratympanic Steroid Injection With Oral Steroids in Patients With Acute Acoustic Trauma
    Article Snippet: Address correspondenc M.D., Department of Otor Hospital, 1186 Eunhyeon 482-863, Republic of Ko The authors alone are r article.. This work was support Project which is funded (ROK-MND-2017-KMM The authors disclose n DOI: 10.1097/MAO.0 ze the factors associated with the administration of intratympanic steroid Results: The mean ages of each grou years and 22.83 2.64 years, respecti benefits of concurrent injection (ITSI) and oral steroids in patients with acute acoustic trauma (AAT) incurred during military training.. Study Design: Retrospective analysis.

    Article Title: Chlorpheniramine-induced anaphylaxis
    Article Snippet: After receiving emergency care for anaphylaxis, including fluid resuscitation and intravenous steroids treatment with dexamethasone (Dexa-S, Ilsung Pharma Co), she was fully recovered.

    Injection:

    Article Title: Immediate Hypersensitivity Reactions Induced by Triamcinolone in a Patient with Atopic Dermatitis
    Article Snippet: .. During previous intermittent treatment with methylprednisolone tablets (4 mg Methylon; Albogen Korea, Seoul, Korea), dexamethasone injection 5 mg/mL (Dexa-S; Ilsung Pharmaceuticals, Seoul, Korea), and triamcinolone acetonide injection 2.5 mg/mL (TRIAM ® ; Shin Poong Pharmaceuticals, Seoul, Korea), there had been no adverse reaction. ..

    Article Title: Wound Healing Promoting Activity of Tonsil-Derived Stem Cells on 5-Fluorouracil-Induced Oral Mucositis Model
    Article Snippet: Growth medium containing 2 × 10 4 TMSCs was mixed in at a ratio of 1:2 to the Matrigel (MA, BD Biosciences, San Jose, CA, USA) to produce a final volume of 100 μl. .. Dexamethasone disodium phosphate (Ilsung Pharmaceuticals Co., Seoul, Republic of Korea, 5 mg/ml) was diluted to 1 mg/kg in a phosphate-buffered saline (PBS, pH 7.4) solution and injected into the submucosa around the mucosa defect site on day 7 using 26-gauge sterile needle syringe. ..

    Saline:

    Article Title: Wound Healing Promoting Activity of Tonsil-Derived Stem Cells on 5-Fluorouracil-Induced Oral Mucositis Model
    Article Snippet: Growth medium containing 2 × 10 4 TMSCs was mixed in at a ratio of 1:2 to the Matrigel (MA, BD Biosciences, San Jose, CA, USA) to produce a final volume of 100 μl. .. Dexamethasone disodium phosphate (Ilsung Pharmaceuticals Co., Seoul, Republic of Korea, 5 mg/ml) was diluted to 1 mg/kg in a phosphate-buffered saline (PBS, pH 7.4) solution and injected into the submucosa around the mucosa defect site on day 7 using 26-gauge sterile needle syringe. ..

    Sterility:

    Article Title: Wound Healing Promoting Activity of Tonsil-Derived Stem Cells on 5-Fluorouracil-Induced Oral Mucositis Model
    Article Snippet: Growth medium containing 2 × 10 4 TMSCs was mixed in at a ratio of 1:2 to the Matrigel (MA, BD Biosciences, San Jose, CA, USA) to produce a final volume of 100 μl. .. Dexamethasone disodium phosphate (Ilsung Pharmaceuticals Co., Seoul, Republic of Korea, 5 mg/ml) was diluted to 1 mg/kg in a phosphate-buffered saline (PBS, pH 7.4) solution and injected into the submucosa around the mucosa defect site on day 7 using 26-gauge sterile needle syringe. ..



    Similar Products

    94
    MedChemExpress dexa hioc group
    <t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
    Dexa Hioc Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexa/HIOC/pmc13273678-279-15-23
    Average 94 stars, based on 1 article reviews
    dexa hioc group - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Hologic Inc whole body dexa scans
    <t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
    Whole Body Dexa Scans, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexa/body+dxa+scans+whole/pmc09530065-50-12-18
    Average 86 stars, based on 1 article reviews
    whole body dexa scans - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Hologic Inc dexa
    <t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
    Dexa, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexa/dxa/pm42319724-54-4-6
    Average 86 stars, based on 1 article reviews
    dexa - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Dopharma Inc dexa ject dexamethasone injection dopharma 2 animal
    <t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
    Dexa Ject Dexamethasone Injection Dopharma 2 Animal, supplied by Dopharma Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexa/2+animal+dexa+dexamethasone+dopharma+injection+ject/us12653891-700-0-3
    Average 86 stars, based on 1 article reviews
    dexa ject dexamethasone injection dopharma 2 animal - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Tokyo Chemical Industry dexamethasone 21 phosphate disodium salt hydrate dexa
    <t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
    Dexamethasone 21 Phosphate Disodium Salt Hydrate Dexa, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexa/disodium+etidronate+hydrate/10__1002_slash_adfm__76329-234-0-10
    Average 86 stars, based on 1 article reviews
    dexamethasone 21 phosphate disodium salt hydrate dexa - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Matsunami Glass dexa scans
    <t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
    Dexa Scans, supplied by Matsunami Glass, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexa/dexa+scans/pmc13195716-100-24-44
    Average 86 stars, based on 1 article reviews
    dexa scans - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    KUB Technologies Inc 3d dual energy x ray absorptiometry dexa instrument
    <t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
    3d Dual Energy X Ray Absorptiometry Dexa Instrument, supplied by KUB Technologies Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexa/Parameter+3D+Tomosynthesis/pmc13458708-266-8-15
    Average 94 stars, based on 1 article reviews
    3d dual energy x ray absorptiometry dexa instrument - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Hologic Inc dexa scans
    <t>DEXA</t> exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.
    Dexa Scans, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexa/dexa/pmc13175334-123-1-5
    Average 86 stars, based on 1 article reviews
    dexa scans - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    DEXA exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.

    Journal: The Journal of Biological Chemistry

    Article Title: Stress-induced glucocorticoid signaling impairs enteric neurotrophin BDNF–TrkB pathway and drives gastrointestinal dysmotility

    doi: 10.1016/j.jbc.2026.113095

    Figure Lengend Snippet: DEXA exposure significantly delays whole gut transit while downregulating myenteric BDNF expression. A , representative of a myenteric ganglion and surrounding cells from an adult murine small intestinal LM-MP tissue when immunostained with antibodies against glucocorticoid receptor ( red and with ANNA-1 antisera containing anti-Hu antibodies ( green ) shows that GR is expressed by all cells of the LM-MP tissues. GR shows strong nuclear immunoreactivity in a subset of Hu-expressing myenteric cells ( white arrow ) while showing relatively weaker nuclear immunoreactivity in other cells ( yellow arrow ). Nuclei are stained with DAPI ( blue ). The scale bar represents 10 μm. B , graphical representation of the mean ± standard error of the whole gut transit times (assayed using the carmine-red dye method) of two cohorts of mice in male and female sexes, where the mice in the ‘DEXA’ cohort were dosed once with DEXA (5 mg/kg body weight), and the ‘ Control ’ cohort mice were dosed with Vehicle (10% DMSO in Saline). Mice in the DEXA cohort showed significantly longer whole gut transit times on average than mice in the control cohort (n = 5/cohort; mean ± S.E. of WGTT (in min): Males: Control : 145.0 ± 20.12; DEXA: 214.0 ± 17.49, ∗ p < 0.05; Females: Control: 136.0 ± 17.49; DEXA: 226.0 ± 18.12, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). C , cohort of adult male mice dosed with DEXA and sacrificed 4 h later showed a detectable presence in DEXA in their serum and small intestinal tissues, when compared to cohort of adult male mice dosed with vehicle (n = 5/cohort; mean ± S.E. of DEXA conc in tissue (in nmoles/Kg tissue weight): Control : 3.12 ± 4.16; DEXA: 159.4 ± 52.39; mean ± S.E. of DEXA conc in serum (in nM): Control : 6.71 ± 3.03; DEXA: 268.2 ± 59.77; ∗ p < 0.05, two-tailed unpaired Students’ t test). D , adult male mice dosed with DEXA and sacrificed 4 h later showed a significant down regulation in the expression of stress and glucocorticoid-responsive Bdnf IV and Bdnf VI transcripts in their small intestinal LM-MP tissues, when compared to age- and sex-matched mice that were dosed with vehicle (n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control: 1.011 ± 0.104; DEXA: 0.536 ± 0.087, ∗ p < 0.05; mean ± S.E. fold change of Bdnf VI : Control: 1.012 ± 0.110; DEXA: 0.422 ± 0.042, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). E , small intestinal LM-MP tissues from adult male mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of BDNF protein as assessed by ELISA, when compared to tissues from age- and sex-matched mice that were cultured with vehicle. (n = 3/cohort; mean ± S.E. BDNF levels (in pg/g of tissue): Control : 473.0 ± 45.32; DEXA: 85.5 ± 32.63, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). F , small intestinal LM-MP tissues from adult mice that were cultured with DEXA for 4 h showed a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (Males: n = 3/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.002 ± 0.047; DEXA: 0.510 ± 0.099; mean ± S.E. fold change of Bdnf VI : Control : 1.018 ± 0.140; DEXA: 0.520 ± 0.079; Females: n = 4/cohort; mean ± S.E. fold change of Bdnf IV : Control : 1.040 ± 0.168; DEXA: 0.525 ± 0.083; mean ± S.E. fold change of Bdnf VI : Control : 1.014 ± 0.097; DEXA: 0.583 ± 0.045; ∗ p < 0.05, ∗∗ p < 0.01; two-tailed unpaired Students’ t test). G , in separate experiments, small intestinal LM-MP tissues from adult male mice that were cultured with DEXA either for 1 h or for 2 h showed that while 1 h of exposure to DEXA caused no significant change in the expression of either Bdnf IV or VI transcripts (n = 3/treatment; mean ± S.E. fold change of Bdnf-IV : Control: 1.061 ± 0.238; DEXA: 0.795 ± 0.257; mean ± S.E. fold change of Bdnf-VI : Control : 1.086 ± 0.327; DEXA: 0.740 ± 0.083), 2 h exposure of LM-MP to DEXA caused a significant reduction in the abundance of both Bdnf IV and Bdnf VI transcripts (n = 3/treatment at 2 h; mean ± S.E. fold change of Bdnf-IV : Control : 1.020 ± 0.137; DEXA: 0.497 ± 0.049; mean ± S.E. fold change of Bdnf-VI : Control: 1.014 ± 0.114; DEXA: 0.630 ± 0.063), ∗ p < 0.05; two-tailed unpaired Students’ t test). BDNF, brain-derived neurotrophic factor; DEXA, dexamethasone; LM-MP, longitudinal muscle – myenteric plexus; WGTT, whole gut transit time.

    Article Snippet: Mice were first housed in individual cages and then those in the HIOC alone and DEXA + HIOC group were treated with HIOC (MedChemExpress, Cat. No. HY-101446; 50 mg/kg body weight in 10% DMSO, intraperitoneal route), while those in DEXA group were treated with equal volume of 10% DMSO in saline as a control for HIOC (intraperitoneal route).

    Techniques: Expressing, Staining, Control, Saline, Two Tailed Test, Cell Culture, Enzyme-linked Immunosorbent Assay, Derivative Assay

    HIOC ameliorates delayed whole gut motility in mice with DEXA -induced dysmotility. DEXA-treated adult male mice that were pre-treated with HIOC - the synthetic and specific agonist of TrkB - showed significant reduction in their WGTT of orally gavaged carmine-red dye, and hence improved whole gut motility, when compared to age- and sex-matched mice that were dosed only with DEXA (n = 9/cohort; mean ± S.E. of WGTT (in min): DEXA only : 228.3 ± 7.12; DEXA + HIOC : 150.0 ± 21.94). By contrast, HIOC dosing of mice in the absence of DEXA treatment does not cause any change in the WGTT of mice (n = 5/cohort; mean ± S.E. of WGTT ( in min ): Vehicle control ( No DEXA + No HIOC) : 151.0 ± 15.44; HIOC only : 154.0 ± 13.91. Statistically significant main effects found for DEXA treatment, F(1, 24) = 4.419, p = 0.0462; for HIOC treatment, F(1, 24) = 4.663, p = 0.0410; and for interaction between DEXA and HIOC treatments, F(1, 24) = 5.436, p = 0.0285 (Two-Way ANOVA). Sidak’s multiple comparisons test reveals statistically significant differences between DEXA+/HIOC- and DEXA+/HIOC+ mice; between DEXA+/HIOC- and DEXA-/HIOC+ mice; and between DEXA+/HIOC- and DEXA-/HIOC+ mice. Differences between all other comparisons were found to be not statistically significant (∗p adj < 0.05, ∗∗p adj < 0.01, ns = p adj > 0.05). WGTT, whole gut transit time; DEXA, dexamethasone.

    Journal: The Journal of Biological Chemistry

    Article Title: Stress-induced glucocorticoid signaling impairs enteric neurotrophin BDNF–TrkB pathway and drives gastrointestinal dysmotility

    doi: 10.1016/j.jbc.2026.113095

    Figure Lengend Snippet: HIOC ameliorates delayed whole gut motility in mice with DEXA -induced dysmotility. DEXA-treated adult male mice that were pre-treated with HIOC - the synthetic and specific agonist of TrkB - showed significant reduction in their WGTT of orally gavaged carmine-red dye, and hence improved whole gut motility, when compared to age- and sex-matched mice that were dosed only with DEXA (n = 9/cohort; mean ± S.E. of WGTT (in min): DEXA only : 228.3 ± 7.12; DEXA + HIOC : 150.0 ± 21.94). By contrast, HIOC dosing of mice in the absence of DEXA treatment does not cause any change in the WGTT of mice (n = 5/cohort; mean ± S.E. of WGTT ( in min ): Vehicle control ( No DEXA + No HIOC) : 151.0 ± 15.44; HIOC only : 154.0 ± 13.91. Statistically significant main effects found for DEXA treatment, F(1, 24) = 4.419, p = 0.0462; for HIOC treatment, F(1, 24) = 4.663, p = 0.0410; and for interaction between DEXA and HIOC treatments, F(1, 24) = 5.436, p = 0.0285 (Two-Way ANOVA). Sidak’s multiple comparisons test reveals statistically significant differences between DEXA+/HIOC- and DEXA+/HIOC+ mice; between DEXA+/HIOC- and DEXA-/HIOC+ mice; and between DEXA+/HIOC- and DEXA-/HIOC+ mice. Differences between all other comparisons were found to be not statistically significant (∗p adj < 0.05, ∗∗p adj < 0.01, ns = p adj > 0.05). WGTT, whole gut transit time; DEXA, dexamethasone.

    Article Snippet: Mice were first housed in individual cages and then those in the HIOC alone and DEXA + HIOC group were treated with HIOC (MedChemExpress, Cat. No. HY-101446; 50 mg/kg body weight in 10% DMSO, intraperitoneal route), while those in DEXA group were treated with equal volume of 10% DMSO in saline as a control for HIOC (intraperitoneal route).

    Techniques: Control